Reason for being
We are a Philippine-based pharmaceutical company with a special purpose to help the Filipino skin patients and consumers live, enjoy and pursue their lives to the fullest by providing quality and affordable solutions to their acute and chronic skin and aesthetic problems.
Our presence believes that a business should be inclusive. We have established, maintained and harnessed relationships with dermatologists and other clinicians who are in constant contact with patients around the country. And these patients have access to our homegrown solutions primarily through skin clinics and Mercury Drug for a few of our OTC products.
Reason for being
We are a Philippine-based pharmaceutical company with a special purpose to help the Filipino skin patients and consumers live, enjoy and pursue their lives to the fullest by providing quality and affordable solutions to their acute and chronic skin and aesthetic problems.
It all began when GSK signified its interest in buying Stiefel after the latter floated its desire to sell the business. The intent and spirit to form a homegrown dermatology company among the movers were strong and resolute. The search for interested investors began as soon as the imminent takeover became apparently clear in mid 2009. Even before integration work between the merged companies started in October, the blueprint for the creation of Eskeen has been laid out in Bohol in July 2009. And the rest they say is history. A young history of struggles and successes.
From that moment on, Eskeen has been led by an executive team of experience-wealthy, customer-engaged and sleeves-rolled up individuals who are focused on key functions like marketing, finance, sales, R&D and supply chain.
Meet Your Leadership Team
11 years of providing quality and affordable homegrown solutions
July 2009
September 2009
July 2009
The intent to establish a national company was borne out of talks about the impending acquisition of Stiefel by GSK.
September 2009
The 5 people now comprising the Leadership Team decided not to join the integrated Stiefel-GSKteam.
October 2009
Talks with investors began.
December 2009
Eskeen was incorporated.
January 2010
Organization work and manufacturing facilities sourcing commenced.
May 2010
Commercial operations started with the LT doing admin, regulatory and commercial works by themselves along with 3 medical representatives.
2012 - present
This period was characterized by consistent growth in portfolio and revenue that makes Eskeen currently the biggest homegrown, privately-owned dermatology specialty company in the Philippines.